M&A Deal Summary |
|
|---|---|
| Date | 2013-06-24 |
| Target | Indicia Biotechnology - Immuno Assays Activities |
| Sector | Life Science |
| Buyer(s) | Platine Pharma Services SAS |
| Sellers(s) | Indicia Biotechnology SA |
| Deal Type | Divestiture |
SEARCH BY
Platine Pharma Services SAS is a provider of immune-monitoring services, quantitative measurement of immune response to products that stimulate the immune system.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
Indicia Biotechnology SA is a Contract Manufacturing for the Life Science industry. Company offers industrial production services to Life Sciences companies wishing to outsource the formulation, sterilization and filling of liquid products and reagents (culture media, Medical Devices, pharmaceutical excipients for pharmaceutical use, and so on).
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-03 |
METIS Biotechnologies
Limoges, France METIS Biotechnologies is a developer, producer and marketer of rapid microbiological analysis solutions using flow cytometry. |
Buy | - |
